18th Annual Drug Discovery Summit 2017

Hits:1252 Date: 11/10/2016

Over 250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.

55 presentations, case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry.

See Agenda with speakers & presentations.

6 Interactive Streams :
▶ Drug Discovery Innovation and Strategies, Enabling Technologies
▶ Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
▶ Successful Phenotypic Drug Discovery: High Content Screening
▶ RNAi Screening, Cancer Genomics and Gene Editing for Drug Discovery
▶ Discovery Chemistry, Medicinal and Computational Chemistry
▶ Medicinal Chemistry and Drug Design: Novel Approaches.

Free Webinar: Can’t make the date ? Register & Receive the recording !

Drug Discovery Open Innovation & Outsourcing

Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono

Phenotypic Screening in Drug Discovery- Novel Tools & Applications

Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee

Disruptive Technologies & Artificial Intelligence in Drug Discovery

Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals

““As usual an excellent event and a very comfortable venue. Thank you to Oxford Global for putting together a quality program with broad set of topics and fast paced 30 minute talks. I will surely be returning next year!”
Director, Affinity Screening & In vitro Pharmacology, Merck & Co.

18th Annual Drug Discovery Summit 201718th Annual Drug Discovery Summit 2017